|
AU5584399A
|
|
Acid labile cationic amphiphiles
|
|
AU3676699A
|
|
Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy
|
|
AU3000399A
|
|
Interferon alpha plasmids and delivery systems, and methods of making and using the same
|
|
AU9405498A
|
|
Compositions and methods for gene therapy to treat disease
|
|
AU7173698A
|
|
Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls
|
|
US6034072A
|
|
IL-2 gene expression and delivery systems and uses
|
|
AU5366298A
|
|
Insulin-like growth factor i (igf-i) expression system and methods of use
|
|
CA2265838A1
|
|
Compositions and methods for pulmonary gene delivery
|
|
US6184037B1
|
|
Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
|
|
US5763270A
|
|
Plasmid for delivery of nucleic acids to cells and methods of use
|
|
US6040295A
|
|
Formulated nucleic acid compositions and methods of administering the same for gene therapy
|
